Qingdao Single-Cell Biotechnology Co., Ltd.
PrivateLast Round
Series A
Extension
Jan 19, 2026
Total Funding Raised
$32.69M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Qingdao Single-Cell Biotechnology Co., Ltd. is a biotechnology company that develops and manufactures single-cell analysis instruments and provides solutions for metabolic phenome-based single-cell imaging, sorting, sequencing, and culture.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qingdao Single-Cell Biotechnology Co., Ltd. Comparables
Compare Qingdao Single-Cell Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hooke Instruments Ltd. | 86% | |
| ThinkCyte | 80% | |
| Deepcell | 80% |
Qingdao Single-Cell Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 19, 2026 | ||||
| Strategic | Apr 23, 2024 | ||||
| Series A | Dec 12, 2023 | ||||
| Pre Seed | Jul 2, 2022 |
Qingdao Single-Cell Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qingdao Zhongke Yucheng Investment Management Co., Ltd. | Series A Extension |
| Beiyang Haitang Venture Capital Fund | Series A |
| Zheshang Capital | Series A Extension |
| Hengxu Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
$14.3M round with Zheshang Capital and Qingdao Zhongke Yucheng.
- Apr 23, 2024
Completed a strategic funding round.
Qingdao Single-Cell Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Qingdao Single-Cell Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Qingdao Single-Cell Biotechnology Co., Ltd. a public or private company?
Qingdao Single-Cell Biotechnology Co., Ltd. is a private company.
What is the current stock price of Qingdao Single-Cell Biotechnology Co., Ltd.?
Qingdao Single-Cell Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Qingdao Single-Cell Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Qingdao Single-Cell Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Qingdao Single-Cell Biotechnology Co., Ltd. is not publicly available.
Can I buy Qingdao Single-Cell Biotechnology Co., Ltd. stock?
Qingdao Single-Cell Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Qingdao Single-Cell Biotechnology Co., Ltd.'s last funding round?
Qingdao Single-Cell Biotechnology Co., Ltd.'s most recent funding round was Series A Extension on January 19, 2026.
Who are the main investors in Qingdao Single-Cell Biotechnology Co., Ltd.?
Key investors in Qingdao Single-Cell Biotechnology Co., Ltd. include Hengxu Capital.
Will Qingdao Single-Cell Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Qingdao Single-Cell Biotechnology Co., Ltd..
How can I track Qingdao Single-Cell Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Qingdao Single-Cell Biotechnology Co., Ltd.'s shares on secondary markets.